ExoRNA Bioscience Nanjing Co. Ltd., co-founded in September 2021 by Professor Zhang Chenyu and Dr. Meng Xia, is headquartered in Shenzhen, with subsidiaries in Nanjing and Shanghai. Focused on developing drugs for diseases without cure and unmet clinical needs, particularly in the central nervous system, ExoRNA aspires to become a global leader in platform-based innovative nucleic acid therapeutics. The company boasts a unique self-assembling exosome nucleic acid delivery platform with multiple organ targeting capabilities, the ability to cross the blood-brain barrier, high safety, and low cost, offering an all-in-one solution to current RNA drug delivery challenges.

Disease Domain	Count

Nervous System Diseases	1

Top 5 Drug Type	Count

siRNA	1

Top 5 Target	Count

LAMP-2(Lysosome-associated membrane glycoprotein 2)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 21 Dec 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 1

Current Projects

Drug(Targets)	Indications	Global Highest Phase

ER-2001 ( LAMP-2 )	Huntington Disease More	Phase 1

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis